What is the recommended management for a patient on Adderall (mixed amphetamine salts) with a urine drug screen positive for THC (tetrahydrocannabinol) and buprenorphine, negative for amphetamines, and no buprenorphine prescription in the prescription drug monitoring program?

Immediate Action: Discontinue Adderall and Conduct a Direct Patient Discussion

This patient should have their Adderall prescription immediately discontinued or held pending clarification, and you must have a non-judgmental, direct conversation with the patient about the unexpected urine drug screen findings before making any further treatment decisions. 1

Critical Findings Requiring Immediate Attention

This urine drug screen reveals three major red flags:

1. Negative for amphetamines despite prescribed Adderall - The patient is not taking their prescribed stimulant medication
2. Positive for buprenorphine - The patient is using an opioid that is not prescribed to them (confirmed by PDMP)
3. Positive for THC - Concurrent illicit substance use

Step-by-Step Management Algorithm

Step 1: Confirm Test Accuracy (Same Day)

• Discuss results with the laboratory or toxicologist immediately 1
• Consider confirmatory testing using gas chromatography-mass spectrometry (GC-MS) if not already performed, as immunoassays can produce false-negatives for amphetamines 2, 3
• Note: Adderall contains both d- and l-amphetamine enantiomers, and some immunoassays have poor cross-reactivity with the l-enantiomer 4, 5
• However, a completely negative amphetamine screen in someone prescribed daily Adderall is highly suspicious for non-adherence

Step 2: Patient Discussion (Within 24-48 Hours)

Before the appointment, inform the patient you need to discuss their urine test results 1, 6

During the conversation:

• Explain that testing is for safety purposes, not punitive 1
• Ask directly: "Can you explain why your test didn't show the Adderall I prescribed but did show buprenorphine?"
• Explore possible explanations:
  • Is the patient selling/diverting their Adderall?
  • Is the patient using unprescribed buprenorphine for self-treatment of opioid use disorder?
  • Is there an undiagnosed opioid use disorder?

Step 3: Assess for Substance Use Disorder

You must consider the strong possibility of substance use disorder 1, 6, 1

Key assessment points:

• The combination of not taking prescribed stimulants + using unprescribed opioids + THC use strongly suggests active substance use disorder
• Adults with ADHD have high rates of comorbid substance abuse 7
• Unprescribed buprenorphine use may indicate the patient is attempting self-treatment for opioid dependence 8

Step 4: Immediate Treatment Modifications

Discontinue or hold the Adderall prescription 1:

• A negative test for prescribed medication indicates the patient is not taking it 1, 6
• When patients are not taking prescribed controlled substances, you can discontinue without tapering 6
• Continuing to prescribe a stimulant the patient isn't taking creates diversion risk and potential harm to others

Address the buprenorphine finding:

• If the patient has opioid use disorder, they need proper buprenorphine treatment through appropriate channels, not illicit use
• Refer for addiction medicine evaluation and formal buprenorphine treatment 8
• Note: Buprenorphine can be difficult to detect on standard immunoassays and often requires GC-MS confirmation 9, but in this case it WAS detected, confirming use

Step 5: Do NOT Abandon the Patient

Critical: You must not dismiss this patient from your practice based on these findings 1, 6, 1

The guidelines are explicit that dismissing patients based on urine drug test results:

• Adversely affects patient safety
• Represents potential patient abandonment
• Results in missed opportunities for lifesaving interventions

Step 6: Coordinate Appropriate Care

Offer or arrange the following:

• Referral to addiction medicine or substance use disorder treatment 8
• Mental health evaluation (depression, bipolar disorder, and personality disorders are common comorbidities) 8
• If opioid use disorder is confirmed, facilitate proper buprenorphine treatment through qualified providers
• Consider whether the ADHD diagnosis is accurate or if symptoms are substance-related

Common Pitfalls to Avoid

1. Don't assume the test is wrong without confirmation - While false-negatives for amphetamines can occur 2, 3, a completely negative screen is more likely non-adherence
2. Don't continue prescribing Adderall "to maintain the relationship" - This enables diversion and violates your duty to prevent harm
3. Don't focus only on the THC - The buprenorphine and negative amphetamine findings are far more concerning
4. Don't dismiss the patient - This is explicitly contraindicated and harmful 1
5. Don't delay the conversation - Time-sensitive intervention is needed

Documentation Requirements

Document thoroughly:

• UDS results and your discussion with the laboratory
• Detailed conversation with patient and their explanations
• Your clinical reasoning for discontinuing Adderall
• Referrals offered and patient's response
• Plan for ongoing care and follow-up

The Bottom Line

This patient likely has active substance use disorder with probable diversion of prescribed stimulants and self-medication with illicit buprenorphine. The appropriate response is to stop the Adderall, maintain the therapeutic relationship, assess for substance use disorder, and facilitate proper addiction treatment rather than continuing to prescribe a controlled substance the patient is not taking.